The Romanian Competition Council fines two suppliers of prescription-only medicines and their distributors for parallel export restrictions (Baxter / Belupo)

On 28 October 2011, the Romanian Competition Council (the “Council”) published Decisions n° 51 and 52/28.10.2011 sanctioning two suppliers of prescription-only medicines - Belupo Iijekovi & kozmetica d.d. Croatia (“Belupo”) and Baxter AG Switzerland (“Baxter”) - and their distributors on the Romanian market for restricting parallel exports outside the Romanian market. These are the first two decisions issued by the Council dealing with agreements between undertakings for restricting parallel trade caught under both article 5 (1) from the Competition Law n° 21/1996 (the “Competition Law”) and article 101 (1) of the Treaty on the Functioning of the European Union (“TFUE”). The Council also made public that fines for similar infringements have been applied to other suppliers and its local

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Authors

Quotation

Carmen Peli, Carmen Korsinszki, The Romanian Competition Council fines two suppliers of prescription-only medicines and their distributors for parallel export restrictions (Baxter / Belupo), 28 October 2011, e-Competitions Bulletin Parallel imports, Art. N° 44497

Visites 1587

All issues

  • Latest News issue 
  • All News issues
  • Latest Special issue 
  • All Special issues